Best Mutual Funds: These flexi caps gave more than 20 percent annualised return in past 5 years
Typically, past returns do not guarantee future returns, but they certainly give an indication of how the scheme has been performing in the recent past and what trajectory of returns it could take in future.
Here, we list out the top performing flexi cap mutual funds which have delivered more than 20 percent annualised return in the past five years. This means if someone had invested ₹ one lakh five years ago, the investment would have swelled to ₹ 2.48 lakh by now.
Flexi cap mutual funds refer to schemes which have invested a minimum of 65 percent in equity and equity-related instruments. These schemes are flexible to invest in schemes across market capitalisation i.e., large cap, small cap and mid cap.
There are 40 flexi cap mutual fund schemes with total AUM (assets under management) of ₹ 4.94 lakh crore, shows the latest AMFI data as on June 30, 2025. Flexi Cap mutual funds Aditya Birla Sun Life Flexi Cap 21.33 Bank of India Flexi Cap 27.16 DSP Flexi Cap 21.05 Edelweiss Flexi Cap 22.68 Franklin India Flexi Cap 25.21 HDFC Flexi Cap Fund 28.50 HSBC Flexi Cap Fund 22.54 JM Flexi Cap 25.50 Parag Parikh Flexi Cap 23.96 Quant Flexi Cap 30.56 Union Flexi Cap 21
(Source: AMFI; returns as on July 21, 2025)
As one can see from the table above, HDFC flexi Cap fund gave 28.50 percent annualised return in the past five years, Franklin India Flexi Cap Fund has delivered 25.21 percent return and Bank of India Flexi Cap Fund delivered 27.16 percent return.
Meanwhile, it is important to mention here that the historical returns do not guarantee future returns. In other words, just because a scheme has delivered good returns in the past, it does not mean that it will surely deliver good returns in the future as well.
For all personal finance updates, visit here
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Capitalmind gets Zerodha's Rainmatter backing after MF debut success
Capitalmind Financial Services Pvt Ltd (CFSPL), a Sebi-registered portfolio manager known for its quantitative investment strategies, has received its first institutional funding through a Series-A investment from Rainmatter, the fintech-focused initiative of Zerodha Broking Ltd. The funding comes on the heels of Capitalmind's mutual fund debut, as its Flexi Cap Fund reopens for subscriptions today after raising ₹45 crore during its New Fund Offer (NFO). Of this, around 75 per cent came through direct plans -- nearly half routed via Zerodha's Coin platform, according to a Capitalmind statement. Direct plans dominate fund inflows The high share of direct inflows reflects investor trust, and also marks a shift in Capitalmind's distribution approach. The remaining 25 per cent of the NFO corpus was raised through regular plans, suggesting early traction among distributors. This is a notable change from Capitalmind's portfolio management services (PMS) business, where distributors account for under 3 per cent of the clientele. The company's flat-fee structure for brokerages is being seen as a step towards making distribution more equitable and transparent. A long-standing relationship The investment formalises a long-standing association between Zerodha founder Nithin Kamath and Capitalmind founder Deepak Shenoy. Shenoy was an early advisor to Zerodha in 2010, and both companies have since shared a focus on investor education. Zerodha's outreach platforms -- including the Varsity education portal, TradingQnA forum, and Zero1 YouTube channel -- have grown in parallel with Capitalmind's content-driven model of blogs, podcasts, and research. Kamath said, "We want to back innovative companies that share our mission of helping Indians do better with their money. My conversations with Deepak about finance and technology started back in 2009, and I've always been impressed by Capitalmind's data-driven, transparent approach. This is a financial investment to support them as they build out their asset management company. In line with Sebi regulations, our stake is capped at 10 per cent, and we will not have a board seat, ensuring their independence." Capitalmind eyes broader retail base Capitalmind's founder Deepak Shenoy sees the Rainmatter investment as a validation of the company's evolution from a financial blog into a full-stack asset management firm. "Nithin's work in sparking my interest in quantitative trading years ago was a pivotal moment for me," Shenoy said. "Having Rainmatter invest in our vision is a powerful validation of our journey. This capital allows us to accelerate our mission of filling a crucial market gap. The professional fee-only advisory ecosystem hasn't scaled as hoped, leaving investors to navigate a complex landscape. We aim to bridge that gap through accessible, solution-oriented products, much like the target-date funds discussed in Sebi's recent consultation paper." Distinct strategies for mutual fund and PMS businesses Capitalmind plans to operate its mutual fund and PMS businesses on separate tracks. The mutual fund arm will focus on scalable retail products, while the PMS division will continue targeting HNIs and ultra-HNIs with customised asset allocation strategies that emphasise tax efficiency. The PMS segment currently manages over ₹450 crore, largely through baskets of mutual funds. Though Capitalmind accounts for just 0.5 per cent of the PMS industry's discretionary AUM, Shenoy sees far more scope in the retail mutual fund space. With industry projections estimating a 15 per cent CAGR, taking total AUM to ₹200 trillion over the next seven years, Shenoy believes capturing even 0.5 per cent of that future market could translate to ₹1 trillion in assets -- a significant milestone for the firm.
Business Standard
8 hours ago
- Business Standard
Nifty below 24,600 level; PSU bank shares in demand
The key equity indices witnessed modest losses in afternoon trade. The Nifty traded a tad below the 24,600 level. PSU bank shares advanced after declining in the previous trading session. At 14:30 IST, the barometer index, the S&P BSE Sensex, shed 82.85 points or 0.10% to 80,627.40. The Nifty 50 index fell 53.75 points or 0.22% to 24,595.80. The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index declined 0.92% and the S&P BSE Small-Cap index fell 1.06%. The market breadth was weak. On the BSE, 1,302 shares rose and 2,673 shares fell. A total of 157 shares were unchanged. RBI Monetary Policy Meeting Outcome: Banking stocks edged lower after the Reserve Bank of Indias Monetary Policy Committee (MPC) unanimously decided to keep the policy repo rate unchanged at 5.5% in its latest review, concluding on 6 August 2025. The committee maintained its stance amid global uncertainties and a resilient domestic economy, choosing to allow more time for the transmission of its earlier rate cuts. Accordingly, the standing deposit facility (SDF) rate remains at 5.25%, while the marginal standing facility (MSF) rate and the bank rate are unchanged at 5.75%. The RBI reiterated its commitment to achieving the medium-term inflation target of 4%, within a tolerance band of +/- 2%, while continuing to support growth. It noted that the global environment remains uncertain, with muted growth and uneven disinflation, although financial volatility has eased somewhat. On the domestic front, growth remains stable. Rural consumption and robust government capital spending are supporting demand, while a normal monsoon is benefiting agriculture. Services and construction activity remain strong, although industrial performance is uneven, weighed down by electricity and mining. The central bank retained its real GDP growth forecast for FY26 at 6.5%, with quarterly projections of 6.5% in Q1, 6.7% in Q2, 6.6% in Q3, and 6.3% in Q4. For Q1 FY27, growth is projected at 6.6%, with risks broadly balanced. On inflation, the RBI lowered its CPI forecast for FY26 to 3.1%, down from the earlier 3.7%. Quarterly inflation is now seen at 2.1% in Q2, 3.1% in Q3, and 4.4% in Q4. CPI inflation for Q1 FY27 is projected at 4.9%. The central bank noted that average inflation this year is expected to remain well below the target, largely due to easing food prices, although inflation may edge above the 4% mark from Q4 onwards. The RBI highlighted that the full impact of the 100 basis points of rate cuts since February 2025 is still unfolding. Given the current macroeconomic conditions and external risks, the MPC decided to maintain the existing rate and continue with a neutral stance. It also signalled continued data monitoring to guide future policy moves. The minutes of the meeting will be released on August 20, while the next MPC meeting is scheduled from September 29 to October 1. Buzzing Index: The Nifty PSU Bank index rose 0.81% to 6,904.10. The index shed 0.15% in the past trading sessions. Union Bank of India (up 2.67%), Canara Bank (up 1.81%), Bank of India (up 1.21%), Bank of Baroda (up 0.81%), State Bank of India (up 0.74%), Punjab National Bank (up 0.46%), Indian Bank (up 0.37%) and Central Bank of India (up 0.36%) advanced. On the other hand, UCO Bank (down 1.59%), Bank of Maharashtra (down 0.94%) and Punjab & Sind Bank (down 0.63%) edged lower. Numbers to Track: The yield on India's 10-year benchmark federal paper rose 1.19% to 6.399 from the previous close of 6.324. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 87.6550 compared with its close of 87.8800 during the previous trading session. MCX Gold futures for 3 October 2025 settlement shed 0.51% to Rs 100,820. The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.01% to 98.77. The United States 10-year bond yield rose 0.86% to 4.243. In the commodities market, Brent crude for October 2025 settlement added $1, or 1.48% to $68.64 a barrel. Stocks in Spotlight: Sandesh hit an upper circuit of 20% after reporting a 14.95% year-on-year rise in consolidated net profit at Rs 58.04 crore for Q1 June 2025, compared to Rs 50.49 crore a year ago. Net sales rose 6.82% to Rs 73.33 crore from Rs 68.65 crore in the corresponding period of the previous year. Divis Laboratories slipped 4.75% after the pharma majors consolidated net profit declined 17.67% to Rs 545 crore in Q1 FY26 as against Rs 662 crore recorded in Q4 FY25. Revenue from operations also declined 6.79% quarter on quarter (QoQ) to Rs 2,410 crore for the quarter ended 30 June 2025.
Business Standard
10 hours ago
- Business Standard
Nifty trades below 24,650 mark; pharma shares skid amid looming tariff concerns
The key equity indices traded with minor cuts in the early afternoon trade as the Reserve Bank of India kept the repo rate unchanged at 5.5% and maintained a neutral policy stance. The Nifty hovered below the 24,650 mark. Pharma shares declined as Donald Trump plans to impose new tariffs on pharmaceuticals. The index tumbled in the past two trading sessions. At 12:25 IST, the barometer index, the S&P BSE Sensex, dropped 20.01 points or 0.02% to 80,690.24. The Nifty 50 index declined 37.10 points or 0.14% to 24,613.60. The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index declined 0.79% and the S&P BSE Small-Cap index fell 1.12%. The market breadth was weak. On the BSE, 1,204 shares rose and 2,656 shares fell. A total of 167 shares were unchanged. RBI Monetary Policy Meeting Outcome: Banking stocks edged lower after the Reserve Bank of Indias Monetary Policy Committee (MPC) unanimously decided to keep the policy repo rate unchanged at 5.5% in its latest review, concluding on 6 August 2025. The committee maintained its stance amid global uncertainties and a resilient domestic economy, choosing to allow more time for the transmission of its earlier rate cuts. Accordingly, the standing deposit facility (SDF) rate remains at 5.25%, while the marginal standing facility (MSF) rate and the bank rate are unchanged at 5.75%. The RBI reiterated its commitment to achieving the medium-term inflation target of 4%, within a tolerance band of +/- 2%, while continuing to support growth. It noted that the global environment remains uncertain, with muted growth and uneven disinflation, although financial volatility has eased somewhat. On the domestic front, growth remains stable. Rural consumption and robust government capital spending are supporting demand, while a normal monsoon is benefiting agriculture. Services and construction activity remain strong, although industrial performance is uneven, weighed down by electricity and mining. The central bank retained its real GDP growth forecast for FY26 at 6.5%, with quarterly projections of 6.5% in Q1, 6.7% in Q2, 6.6% in Q3, and 6.3% in Q4. For Q1 FY27, growth is projected at 6.6%, with risks broadly balanced. On inflation, the RBI lowered its CPI forecast for FY26 to 3.1%, down from the earlier 3.7%. Quarterly inflation is now seen at 2.1% in Q2, 3.1% in Q3, and 4.4% in Q4. CPI inflation for Q1 FY27 is projected at 4.9%. The central bank noted that average inflation this year is expected to remain well below the target, largely due to easing food prices, although inflation may edge above the 4% mark from Q4 onwards. The RBI highlighted that the full impact of the 100 basis points of rate cuts since February 2025 is still unfolding. Given the current macroeconomic conditions and external risks, the MPC decided to maintain the existing rate and continue with a neutral stance. It also signalled continued data monitoring to guide future policy moves. The minutes of the meeting will be released on August 20, while the next MPC meeting is scheduled from September 29 to October 1. Derivatives: The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, up 0.98% to 11.83. The Nifty 31 July 2025 futures were trading at 24,669 at a premium of 55.4 points as compared with the spot at 24,613.60. The Nifty option chain for the 28 August 2025 expiry showed a maximum call OI of 57.2 lakh contracts at the 25,000 strike price. Maximum put OI of 38.6 lakh contracts was seen at 24,000 strike price. Buzzing Index: The Nifty Pharma index declined 1.49% to 21,642.70. The index fell 2.31% in the past two trading sessions. Divis Laboratories (down 3.71%), Laurus Labs (down 3.18%), Ajanta Pharma (down 2.88%), Granules India (down 2.76%) and Zydus Lifesciences (down 2.43%), Biocon (down 2.42%), Alkem Laboratories (down 2.2%), Dr Reddys Laboratories (down 2.14%), Natco Pharma (down 2.02%) and J B Chemicals & Pharmaceuticals (down 2%) delcined. Stocks in Spotlight: Bharti Airtel rose 0.31%. The company has reported 103.3% rise in consolidated net profit to Rs 5,948 crore in Q1 FY26 from Rs 2,925 crore in Q1 FY25. Total revenues increased by 28.5% YoY to Rs 49,463 crore in the April June 2025 quarter. The growth was driven by strong momentum in both India and Africa. CCL Products (India) tanked 6.06% after the companys consolidated net profit fell 28.88% to Rs 72.44 crore in Q1 FY26, compared with Rs 101.86 crore in Q4 FY25. However, revenue from operations jumped 26.29% Quarter on Quarter (QoQ) to Rs 1,055.63 crore in Q1 FY26.
